Table 2.
Characteristics and descriptions of the features used in this study.
| Feature | Class | Total (1517) | COPVID-19 Nengative (363) | COVID-19 Positive (1054) | |||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| Symptoms | |||||||
| Fever | True | 832 | (58.7%) | 199 | (54.8%) | 633 | (60%) |
| False | 585 | (41.3%) | 164 | (45.2%) | 421 | (40.0%) | |
| Fatigue | True | 466 | (32.9%) | 144 | (39.7%) | 322 | (30.6%) |
| False | 951 | (67.1%) | 219 | (60.3%) | 732 | (69.4%) | |
| Dry-Cough | True | 830 | (58.6%) | 200 | (55.1%) | 630 | (59.8%) |
| False | 587 | (41.4%) | 163 | (44.9%) | 424 | (40.2%) | |
| Headache | True | 444 | (31.3%) | 126 | (34.7%) | 318 | (30.2%) |
| False | 973 | (68.7%) | 217 | (65.3%) | 756 | (69.8%) | |
| Pains | False | 185 | (13.1%) | 45 | (12.4%) | 140 | (13.3%) |
| True | 1232 | (86.9%) | 318 | (87.6%) | 914 | (86.7%) | |
| Difficulty in Breathing | True | 397 | (28.0%) | 151 | (41.6%) | 246 | (23.3%) |
| False | 1020 | (72%) | 412 | (58.4%) | 808 | (76.7%) | |
| Sore-Throat | True | 322 | (22.7%) | 93 | (25.6%) | 229 | (21.7%) |
| False | 1095 | (77.3%) | 270 | (74.4%) | 825 | (79.3%) | |
| Anosmia | True | 154 | (10.9%) | 18 | (5.0%) | 136 | (12.9%) |
| False | 1263 | (89.1%) | 345 | (95.0%) | 918 | (87.1%) | |
| Ageusia | True | 96 | (6.8%) | 8 | (2.2%) | 88 | (8.3%) |
| False | 1321 | (93.2%) | 355 | (97.8%) | 966 | (91.7%) | |
| Diarrhea | True | 213 | (15.0%) | 55 | (15.2%) | 158 | (15.0%) |
| False | 1204 | (85.0%) | 308 | (84.8%) | 896 | (85.0%) | |
| No Symptom | True | 63 | (4.0%) | 1 | (0.3%) | 62 | (5.0%) |
| False | 1354 | (96.0%) | 362 | (99.7%) | 992 | (94.1%) | |
| Basic information The age of a tested individual is based on the WHO age group standard. | |||||||
| Age_0-9 | True | 24 | (1.7%) | 1 | (0.3%) | 23 | (2.2%) |
| False | 1393 | (98.3%) | 362 | (99.7%) | 1031 | (97.8%) | |
| Age_10-19 | True | 60 | (4.2%) | 20 | (5.5%) | 40 | (3.8%) |
| False | 1357 | (95.8%) | 343 | (94.5%) | 1014 | (96.2%) | |
| Age_20-24 | True | 106 | (7.5%) | 30 | (8.3%) | 76 | (7.2%) |
| False | 1311 | (92.5%) | 333 | (91.7%) | 978 | (92.8%) | |
| Age_25-59 | True | 920 | (64.9%) | 227 | (62.5%) | 693 | (65.7%) |
| False | 497 | (35.1%) | 136 | (47.5) | 361 | (34.3%) | |
| Age_60+ | True | 304 | (21.5%) | 84 | (23.1%) | 220 | (20.9%) |
| False | 1113 | (78.5%) | 279 | (76.9%) | 834 | (79.%) | |
| Gender Female | True | 671 | (47.4%) | 161 | (44.4%) | 510 | (48.4%) |
| False | 746 | (52.6%) | 202 | (55.6%) | 544 | (51.6%) | |
| Gender Male | True | 746 | (52.6%) | 202 | (55.6%) | 544 | (51.6%) |
| False | 671 | (47.4%) | 161 | (44.4%) | 510 | (48.4%) | |
| The severity of a patients’ illness | |||||||
| Severity Mild | True | 967 | (68.2%) | 181 | (49.9%) | 786 | (74.6%) |
| False | 450 | (31.8%) | 182 | (99.7%) | 268 | (26.4%) | |
| Severity Moderate | True | 396 | (27.9%) | 158 | (43.5%) | 238 | (22.6%) |
| False | 1021 | (72.1%) | 205 | (56.%) | 816 | (77.4%) | |
| Severity Severe | True | 45 | (3.2%) | 21 | (5.8%) | 24 | (2.3%) |
| False | 1372 | (96.8%) | 342 | (94.2%) | 1030 | (97.7%) | |
| Severity Critical | True | 10 | (0.7%) | 3 | (0.8%) | 7 | (0.7%) |
| False | 1407 | (99.3%) | 360 | (99.2%) | 1047 | (99.3%) | |
| Commorbidity | |||||||
| None Experiencing | True | 1,189 | (83.9%) | 314 | (86.5%) | 875 | (83.0%) |
| False | 228 | (16.1%) | 49 | (13.5%) | 179 | (17.0%) | |